Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
3.380
-0.070 (-2.03%)
Nov 21, 2024, 11:45 AM EST - Market open
Kiora Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 10 | 4 | 6 | 19 | 27 | 41 | |
| Market Cap Growth | 164.26% | -34.81% | -67.75% | -29.68% | -33.02% | 100.75% | |
| Enterprise Value | -19 | -1 | 1 | 8 | 25 | 38 | |
| Last Close Price | 3.42 | 4.70 | 30.87 | 543.60 | 1774.80 | 3607.20 | |
| PS Ratio | 0.65 | - | - | - | 2252.98 | 15.10 | |
| PB Ratio | 0.34 | 0.66 | 0.54 | 1.31 | 2.79 | 6.13 | |
| P/TBV Ratio | 0.47 | 0.67 | 0.55 | 1.33 | 4.60 | 8.32 | |
| EV/Sales Ratio | - | - | - | - | 2038.07 | 14.23 | |
| Debt / Equity Ratio | 0.00 | 0.02 | 0.01 | 0.01 | 0.06 | 0.01 | |
| Asset Turnover | 0.59 | - | - | - | 0.00 | 0.22 | |
| Quick Ratio | 8.84 | 2.76 | 2.24 | 5.21 | 0.64 | 2.67 | |
| Current Ratio | 8.97 | 2.90 | 2.35 | 5.59 | 0.87 | 3.06 | |
| Return on Equity (ROE) | 29.11% | -142.88% | -104.54% | -113.30% | -83.92% | -91.22% | |
| Return on Assets (ROA) | 14.00% | -33.54% | -34.55% | -37.30% | -36.91% | -33.87% | |
| Return on Capital (ROIC) | 19.93% | -61.27% | -50.98% | -52.67% | -55.15% | -52.80% | |
| Earnings Yield | 54.63% | -311.53% | -220.45% | -72.08% | -25.26% | -17.50% | |
| FCF Yield | 80.51% | -237.92% | -169.24% | -56.21% | -27.01% | -20.10% | |
| Buyback Yield / Dilution | -789.70% | -561.21% | -203.73% | -110.04% | - | - | |
| Total Shareholder Return | -789.70% | -561.21% | -203.73% | -110.04% | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.